SARS-CoV-2 mRNA Vaccination Elicits Robust Antibody Responses in Children

The authors deeply profiled the vaccine-induced humoral immune response in 6 to 11 year old children receiving either a pediatric or adult dose of the mRNA-1273 vaccine and compared these responses to vaccinated adults, infected children, and children that experienced multisystem inflammatory syndrome in children.